Health

VWR International Corporate Office

VWR International was founded by George Van Waters and Nat Rogers as a chemical company in the 1920’s.

In 1995 Merck, a German pharmaceutical company, purchased VWR and merged it with Merck Eurolab, thereby creating a global laboratory distributor. In 2007 the company was sold to the private equity company Madison Dearborn Partners.

Today VWR International is a global distributor of scientific and technology laboratory supplies, including instruments, glassware, chemicals, protective clothing, and production replies. The company has operations in 35 countries.

In October of 2014 VWR went public with a $536 million Initial Public Offering.

VWR International is publicly traded on the NASDAQ under the ticker symbol VWR, is #583 in the Fortune 1000, has 8,500 employees, and had $4.33 billion in revenue in 2013.

VWR International

VWR International was founded by George Van Waters and Nat Rogers as a chemical company in the 1920’s.

History

In October of 2014 VWR went public with a $536 million Initial Public Offering.

VWR International is publicly traded on the NASDAQ under the ticker symbol VWR, is #583 in the Fortune 1000, has 8,500 employees, and had $4.33 billion in revenue in 2013.

Molina Healthcare Corporate Office

Molina Healthcare was founded in 1980 by Dr. David Molina in Long Beach, California. Dr. Molina was an emergency room physician. He noticed that patients were coming to the emergency room for common illnesses such as flu because doctors would not accept Medi-Cal. He established a clinic with the goal of treating low-income patients.

The company is a family business, run by founder David Molina’s sons, Joseph Mario Molina and John C. Molina.

Today Molina Healthcare continues with its mission of helping Medicaid and Medicare members find appropriate healthcare services for their needs. Its Health Plan segment serves almost 2 million people.

Molina Healthcare is traded publicly on the New York Stock Exchange under the ticker symbol MOH, is a member of the S&P 600, is #393 in the Fortune 500, has 8,200 employees, and had $14.18 billion in revenue in 2015.

Molina Healthcare

The company is a family business, run by founder David Molina’s sons, Joseph Mario Molina and John C. Molina.

History

Hospira Corporate Office

Hospira is a pharmaceutical and medical device company.

The company was formed in 2004 when Abbot Laboratories spun-off its hospital products division. The name “Hospira” was chosen by a vote of the employees and is a combination of the words hospital, spirit, inspire, and the Latin word for hope, spero.

At the time of the spin-off, Hospira had 14 manufacturing sites, 14,000 employees, and $2.5 billion in sales annually.

Today Hospira produces mostly generic specialty injectable pharmaceuticals for cardiovascular, anesthesia, oncology, and anti-infective therapies as well as pre-filled syringes. The company also manufactures electronic drug pumps and infusion therapy devices. Customers include wholesalers, drug manufacturers, nursing centers, outpatient surgical care facilities, and hospitals.

Hospira trades publicly on the New York Stock exchange under the ticker symbol HSP, is a member of the S&P 500, is #606 in the Fortune 500, has 17,000 employees, and had $4.42 billion in revenue in 2013.

Hospira

Hospira is a pharmaceutical and medical device company.

At the time of the spin-off, Hospira had 14 manufacturing sites, 14,000 employees, and $2.5 billion in sales annually.

History

Forest Laboratories Corporate Office

Forest Laboratories was founded in 1956 as a small laboratory service company, helping pharmaceutical companies to create new drugs.

In 1977 the company changed its focus to marketing new and generic drugs, as the then-CEO Howard Solomon wanted to explore this more profitable side of the business.

One notable acquisition was Aerobid, and asthma drug, in 1986. At the time of purchase Aerobid had total sales of $2.3 million. By 1991 Forest had made the drug very profitable, with yearly revenue of $30 million.

Today Forest Laboratories develops and manufactures such drugs as Namenda for Alzheimer’s, Savella for fibromyalgia, Lexapro the antidepressant, Bystolic for hypertension, as well as generic and OTC (over-the-counter) drugs.

Until 2014 Forest was publicly traded on the New York Stock Exchange under the ticker symbol FRX. In 2014 the company was acquired by Actavis in a $25 billion deal.

Forest Laboratories

Forest Laboratories was founded in 1956 as a small laboratory service company, helping pharmaceutical companies to create new drugs.

In 1977 the company changed its focus to marketing new and generic drugs, as the then-CEO Howard Solomon wanted to explore this more profitable side of the business.

History

Until 2014 Forest was publicly traded on the New York Stock Exchange under the ticker symbol FRX. In 2014 the company was acquired by Actavis in a $25 billion deal.

Zimmer Holdings Corporate Office

Zimmer Holdings was founded in 1927 by Justin Zimmer in Warsaw, Indiana to produce aluminum splints. In the first year of production the company reached $160,000 in sales.

The company grew as an orthopedic developer and manufacturer and continually added new offerings to its product portfolio, such as internal bone fixation devices in the 1930’s and titanium-based implant devices in the 1950’s.

Today Zimmer Holdings continues to design and market orthopedic products, including implants used in knee and hip replacements, shoulder implants that restore function to arthritic joints, and tissue and bone grafting materials. The company also produces surgical products such as devices for wound cleansing.

Zimmer Holdings is traded publicly on the New York Stock Exchange under the ticker symbol ZMH, is a member of the S&P 500, is #531 in the Fortune 500, has 9,000 employees, and had $4.69 billion in revenue in 2013.

Zimmer Holdings

Zimmer Holdings was founded in 1927 by Justin Zimmer in Warsaw, Indiana to produce aluminum splints. In the first year of production the company reached $160,000 in sales.